(Q42524581)

1 November 2017

title

Modulation of colonic aberrant crypt foci and proliferative indexes in colon and prostate glands of rats by vitamin E. (English)

1 reference

1 November 2017

Yao K

1

1 reference

1 November 2017

Latta M

series ordinal

2

1 reference

1 November 2017

Bird RP

series ordinal

3

1 reference

1 November 2017

publication date

1 January 1996

1 reference

1 November 2017

1 reference

1 November 2017

volume

26

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

99-109

1 reference

Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01635589609514467

Promotional effects of testosterone and high fat diet on the development of autochthonous prostate cancer in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589609514467

Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589609514467

Dose response and proliferative characteristics of aberrant crypt foci: putative preneoplastic lesions in rat colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589609514467

Colonic aberrant crypt foci are associated with increased expression of c-fos: the possible role of modified c-fos expression in preneoplastic lesions in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589609514467

Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589609514467

The identification of high and low risk groups for colorectal cancer using rectal mucosal crypt cell production rate (CCPR).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589609514467

Is acid phosphatase (PAP) still justified in the management of prostatic cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635589609514467

10.1080/01635589609514467

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference